The role of Zulewski’s clinical score in screening for hypothyroidism in post-radiation therapy nasopharyngeal carcinoma patients
Andhika Rachman 1 * , Dyah Purnamasari 2 , Mardiah Suci Hardianti 3 , Dimas Priantono 1 , Bayu Bijaksana Rumondor 3 , Cosphiadi Irawan 1
More Detail
1 Division of Hematology and Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Central Jakarta, INDONESIA2 Division of Endocrine, Metabolism and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Central Jakarta, INDONESIA3 Division of Hematology and Medical Oncology, Department of Internal Medicine, Dr. Sardjito General Hospital, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, INDONESIA* Corresponding Author

Abstract

Background: Nasopharyngeal carcinoma (NPC) is a leading cause of cancer related death in Asia; and the fourth most common malignancy in Indonesia. Hypothyroidism is one of the most commonly overlooked radiotherapy-induced late side effect due to its gradual occurrence despite its irreversibility. Unfortunately, thyroid evaluation is not widely accessible throughout Indonesia. Therefore, it is quite important to utilize a simple and reliable surrogate tool for hypothyroidism screening. This study aims to evaluate thyroid function and to validate Zulewski’s scoring system as a temporary surrogate marker for hypothyroidism in post-RT NPC patients.
Method: This is a cross-sectional study involving NPC patients between November 2015 and March 2016 at Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia. The patients had completed radiation therapy (RT) within the preceding six months. They were evaluated for signs and symptoms of hypothyroidism with Zulewski’s clinical scoring system and with serological analysis of thyroid stimulating hormone (TSH) and free thyroxine (FT4) levels.
Results: There were 97 patients in this study. 28 (28.9%) subjects experienced hypothyroidism based on the TSH and FT4 levels, with subclinical hypothyroidism (13.4%) as the most common type, followed by overt hypothyroidism (9.3%) and hypothyroxinemia (6.2%). From the subjects with hypothyroidism, 19.6% had Zulewski’s clinical score <5, while 40.5% had scores ≥5. Subjects with <5 Zulewski’s clinical score exhibited signs and symptoms more related to the NPC itself, while those who scored ≥5 showed signs and symptoms more closely related to hypothyroidism.
Conclusion: This study shows that hypothyroidism is commonly exhibited in NPC patients after radiotherapy (28.9%). Zulewski’s clinical score of ≥5 indicates signs and symptoms more closely related to hypothyroidism.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Original Article

ELECTRON J GEN MED, 2022, Volume 19, Issue 6, Article No: em413

https://doi.org/10.29333/ejgm/12414

Publication date: 29 Aug 2022

Article Views: 1147

Article Downloads: 1719

Open Access References How to cite this article